Structure of Vitronectin and its Biological Role in Haemostasis

a putative serine residue to be modified

[1]  K. Preissner,et al.  Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin. , 1991, Biochemistry.

[2]  M. Lampugnani,et al.  An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion , 1991, The Journal of cell biology.

[3]  R. Sato,et al.  Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis. Isolation and characterization of a cDNA clone for the antigen. , 1990, The Journal of biological chemistry.

[4]  P. McKeown-Longo,et al.  Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells , 1990, The Journal of cell biology.

[5]  K. Preissner,et al.  Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. , 1990, The Journal of biological chemistry.

[6]  M. Salmivirta,et al.  Binding of human syndecan to extracellular matrix proteins. , 1990, The Journal of biological chemistry.

[7]  D. Loskutoff,et al.  Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor , 1990, The Journal of cell biology.

[8]  K. Preissner,et al.  Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties. , 1990, The Journal of biological chemistry.

[9]  D. Tollefsen,et al.  The presence of methionine or threonine at position 381 in vitronectin is correlated with proteolytic cleavage at arginine 379. , 1990, The Journal of biological chemistry.

[10]  D. Cheresh,et al.  GLIOBLASTOMA CELLS SYNTHESIZE AND SECRETE THE ADHESIVE PROTEIN VITRONECTIN: 235 , 1990 .

[11]  K. Preissner,et al.  Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator. , 1990, Biochemical and biophysical research communications.

[12]  Y. Sakaki,et al.  Polymorphism of the human vitronectin gene causes vitronectin blood type. , 1990, Biochemical and biophysical research communications.

[13]  P. Højrup,et al.  Sequence location of a putative transglutaminase cross‐linking site in human vitronectin , 1990, FEBS letters.

[14]  D. Sane,et al.  Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers. , 1990, The Journal of biological chemistry.

[15]  J. Mimuro.  [Type 1 plasminogen activator inhibitor]. , 1990, Rinsho byori. The Japanese journal of clinical pathology.

[16]  D. Mosher,et al.  Identification of vitronectin as a major plasma protein adsorbed on polymer surfaces of different copolymer composition. , 1989, Blood.

[17]  K. Preissner,et al.  Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. , 1989, Blood.

[18]  R. Hynes,et al.  An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. , 1989, Blood.

[19]  W. Huttner,et al.  Sulfation of two tyrosine-residues in human complement S-protein (vitronectin). , 1989, European journal of biochemistry.

[20]  D. Mosher,et al.  Conformational lability of vitronectin: induction of an antigenic change by alpha-thrombin-serpin complexes and by proteolytically modified thrombin. , 1989, Biochemistry.

[21]  K. Preissner,et al.  A novel beta-endorphin binding protein. Complement S protein (= vitronectin) exhibits specific non-opioid binding sites for beta-endorphin upon interaction with heparin or surfaces. , 1989, The Journal of biological chemistry.

[22]  D. Cheresh,et al.  Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells , 1989, Cell.

[23]  F. A. Bennett,et al.  A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. , 1989, Journal of cell science.

[24]  B. Dahlbäck,et al.  Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers. , 1989, The Journal of investigative dermatology.

[25]  E. Ruoslahti,et al.  Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. , 1989, The Journal of biological chemistry.

[26]  J. Mimuro,et al.  Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells. , 1989, The Journal of biological chemistry.

[27]  D. Cheresh,et al.  Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. , 1989, The Journal of biological chemistry.

[28]  K. Yamada,et al.  Vitronectin exists in two structurally and functionally distinct forms in human plasma. , 1989, Biochimica et biophysica acta.

[29]  C. Parker,et al.  Vitronectin (S protein) is associated with platelets , 1989, British journal of haematology.

[30]  J. Mimuro,et al.  Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin. , 1989, The Journal of biological chemistry.

[31]  T. Mollnes,et al.  S‐Protein Is Synthesized by Human Monocytes and Macrophages in Vitro , 1989, Scandinavian journal of immunology.

[32]  S. Shaltiel,et al.  Vitronectin is phosphorylated by a cAMP-dependent protein kinase released by activation of human platelets with thrombin. , 1988, Biochemical and biophysical research communications.

[33]  K. Preissner,et al.  Modulation of Heparin Cofactor II Function by S Protein (Vitronectin) and Formation of a Ternary S Protein-Thrombin-Heparin Cofactor II Complex , 1988, Thrombosis and Haemostasis.

[34]  O. Sigurdardottir,et al.  Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma , 1988, FEBS letters.

[35]  T. L. Moser,et al.  Vitronectin is a substrate for transglutaminases. , 1988, Biochemical and biophysical research communications.

[36]  K. Preissner,et al.  Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). , 1988, The Journal of biological chemistry.

[37]  D. Mosher,et al.  Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea. , 1988, Blood.

[38]  E. Dejana,et al.  Fibronectin and vitronectin regulate the organization of their respective Arg-Gly-Asp adhesion receptors in cultured human endothelial cells , 1988, The Journal of cell biology.

[39]  L. Patthy,et al.  Detecting distant homologies of mosaic proteins. Analysis of the sequences of thrombomodulin, thrombospondin complement components C9, C8 alpha and C8 beta, vitronectin and plasma cell membrane glycoprotein PC-1. , 1988, Journal of molecular biology.

[40]  M. Hayashi,et al.  Novel purification of vitronectin from human plasma by heparin affinity chromatography. , 1988, Cell structure and function.

[41]  D. Mosher,et al.  Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. , 1988, Blood.

[42]  K. Preissner,et al.  Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. , 1988, Blood.

[43]  Tadashi,et al.  Identification of the collagen-binding domain of vitronectin using monoclonal antibodies. , 1988, Cell structure and function.

[44]  M. Peitsch,et al.  The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities. , 1988, Biochemistry.

[45]  F. Tatum,et al.  Importance of ligand-induced conformational changes in hemopexin for receptor-mediated heme transport. , 1988, The Journal of biological chemistry.

[46]  A. Woods,et al.  Focal adhesions and cell-matrix interactions. , 1988, Collagen and related research.

[47]  P. Thiagarajan,et al.  Exposure of binding sites for vitronectin on platelets following stimulation. , 1988, The Journal of biological chemistry.

[48]  M. Ginsberg,et al.  Cytoadhesins, Integrins, and Platelets , 1988, Thrombosis and Haemostasis.

[49]  R. Inhorn,et al.  Phosphorylation of vitronectin by a protein kinase in human plasma. Identification of a unique phosphorylation site in the heparin-binding domain. , 1988, The Journal of biological chemistry.

[50]  K. Preissner,et al.  NEUTRALIZATION OF HEPARIN-LIKE SACCHARIDES BY COMPLEMENT S PROTEIN/VITRONECTIN , 1987, Thrombosis and Haemostasis.

[51]  E. Levin,et al.  Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells , 1987, The Journal of cell biology.

[52]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[53]  D. Jenne,et al.  Nucleotide sequence and organization of the human S-protein gene: repeating peptide motifs in the "pexin" family and a model for their evolution. , 1987, Biochemistry.

[54]  D. Mosher,et al.  Interactions of thrombospondin with endothelial cells: receptor- mediated binding and degradation , 1987, The Journal of cell biology.

[55]  K. Preissner,et al.  Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin. , 1987, The Journal of biological chemistry.

[56]  J. Mimuro,et al.  Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. , 1987, Blood.

[57]  K. Preissner,et al.  S protein/vitronectin in chronic liver diseases: correlations with serum cholinesterase, coagulation factor X and complement component C3 , 1987, European journal of haematology.

[58]  K. Preissner,et al.  Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum. , 1987, The Biochemical journal.

[59]  Richard O. Hynes,et al.  Integrins: A family of cell surface receptors , 1987, Cell.

[60]  E. Engvall,et al.  Interaction of vitronectin with collagen. , 1986, The Journal of biological chemistry.

[61]  K. Yamada,et al.  Immunological characterization of human vitronectin and its binding to glycosaminoglycans. , 1986, Journal of biochemistry.

[62]  D. Mosher,et al.  On the identity of vitronectin and S-protein: immunological crossreactivity and functional studies. , 1986, Blood.

[63]  R. Bloch,et al.  Vitronectin at sites of cell-substrate contact in cultures of rat myotubes , 1986, The Journal of cell biology.

[64]  B. Dahlbäck,et al.  Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation. , 1986, The Journal of biological chemistry.

[65]  K. Stanley.  Homology with hemopexin suggests a possible scavenging function for S‐protein/vitronectin , 1986, FEBS letters.

[66]  D. Lane,et al.  Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. , 1986, The Journal of biological chemistry.

[67]  E. Ruoslahti,et al.  Arg-Gly-Asp: A versatile cell recognition signal , 1986, Cell.

[68]  K. Preissner,et al.  Physicochemical, immunochemical and functional comparison of human S-protein and vitronectin. Evidence for the identity of both plasma proteins. , 1986, Biochemical and biophysical research communications.

[69]  E. Ruoslahti,et al.  Association of thrombin-antithrombin III complex with vitronectin in serum. , 1985, The Journal of biological chemistry.

[70]  D. Jenne,et al.  Molecular cloning of S‐protein, a link between complement, coagulation and cell‐substrate adhesion. , 1985, The EMBO journal.

[71]  J. Reing,et al.  Human spreading factor: Synthesis and response by HepG2 hepatoma cells in culture , 1985, Journal of cellular physiology.

[72]  K. Preissner,et al.  Physicochemical characterization of human S-protein and its function in the blood coagulation system. , 1985, The Biochemical journal.

[73]  E. Ruoslahti,et al.  Vitronectin--a major cell attachment-promoting protein in fetal bovine serum. , 1985, Experimental cell research.

[74]  E. Ruoslahti,et al.  Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. , 1985, The EMBO journal.

[75]  J. Reing,et al.  Heparin-binding properties of human serum spreading factor. , 1985, The Journal of biological chemistry.

[76]  D. Jenne,et al.  Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis. , 1985, Thrombosis research.

[77]  B. Dahlbäck,et al.  Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. , 1985, Biochemistry.

[78]  T. Foley,et al.  Quantitation of spreading factor in human biologic fluids. , 1984, The Journal of laboratory and clinical medicine.

[79]  E. Ruoslahti,et al.  Serum spreading factor (vitronectin) is present at the cell surface and in tissues. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[80]  E. Marciniak,et al.  High Molecular Weight Forms of Antithrombin III Complexes in Blood , 1983, Thrombosis and Haemostasis.

[81]  E. Engvall,et al.  Cell attachment on replicas of SDS polyacrylamide gels reveals two adhesive plasma proteins , 1982, The Journal of cell biology.

[82]  M A Shifman,et al.  The in vivo metabolism of antithrombin III and antithrombin III complexes. , 1982, The Journal of biological chemistry.

[83]  H. Müller-Eberhard,et al.  Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. , 1979, The Journal of biological chemistry.

[84]  L. Fryklund,et al.  Primary structure of somatomedin B A growth hormone‐dependent serum factor with protease inhibiting activity , 1978, FEBS letters.

[85]  D. Pepper,et al.  The Different Forms of Antithrombin III in Serum , 1977, Thrombosis and Haemostasis.

[86]  R. Holmes.  PREPARATION FROM HUMAN SERUM OF AN ALPHA-ONE PROTEIN WHICH INDUCES THE IMMEDIATE GROWTH OF UNADAPTED CELLS IN VITRO , 1967, The Journal of cell biology.

[87]  K. Preissner.  Physiological role of vessel wall related antithrombotic mechanisms: contribution of endogenous and exogenous heparin-like components to the anticoagulant potential of the endothelium. , 1990, Haemostasis.

[88]  M. Kazatchkine,et al.  Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex. , 1989, Clinical and experimental immunology.

[89]  M. Ginsberg,et al.  Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor. , 1989, Progress in hemostasis and thrombosis.

[90]  H. Weiss,et al.  Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. , 1989, The Journal of clinical investigation.

[91]  E. Ruoslahti.  Fibronectin and its receptors. , 1988, Annual review of biochemistry.

[92]  L. T. Hunt,et al.  A domain structure common to hemopexin, vitronectin, interstitial collagenase, and a collagenase homolog. , 1987, Protein sequences & data analysis.

[93]  A. Dalmasso,et al.  Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. , 1987, The American journal of pathology.

[94]  E. Ruoslahti,et al.  Purification and characterization of vitronectin. , 1987, Methods in enzymology.

[95]  R. Bar-Shavit,et al.  Mediation of cellular events by thrombin. , 1986, International review of experimental pathology.